FdaApplication
ANDA 211968
Identifiers
- fda_app_no: ANDA211968
Properties
| Property | Value |
|---|---|
| applicant_name | NEPHRON PHARMACEUTICALS CORPORATION |
| application_type | ANDA |
| approval_date | 2020-04-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | SODIUM CHLORIDE | 450MG/50ML (9MG/ML) | SOLUTION;INJECTION |
| SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | SODIUM CHLORIDE | 900MG/100ML | SOLUTION;INJECTION |
2 products